V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005642 | 310002639 | 1.6 | 60.8 | Disease modification (D) | 2017-12-23 | 2018-01-03 | Cisplatin + Doxorubicin | N | N | 310002058 | PAZOPANIB |
| 310005643 | 310002640 | 1.74 | null | Palliative (P) | 2018-11-26 | 2018-11-29 | Cetuximab + Radiotherapy Load | 2 | N | 310002163 | CETUXIMAB + RT |
| 310005644 | 310002641 | 1.8 | 120 | Disease modification (D) | 2018-07-27 | 2018-08-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 310002173 | CETUXIMAB + RT |
| 310005645 | 310002642 | 1.67 | 69 | null | 2018-10-06 | 2018-11-13 | LENALIDOMIDE | N | N | 310002342 | METHOTREXATE |
| 310005646 | 310002643 | 1.61 | null | Curative (C) | 2017-10-19 | 2017-10-25 | BEAM | N | N | 310002475 | CISPLATIN + PEMETREXED |
| 310005647 | 310002643 | 1.83 | null | Curative (C) | 2015-01-18 | 2015-02-15 | CYCLO + ETOPOSIDE + VINCRISTINE | 02 | N | 310002475 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005648 | 310002644 | 0 | null | Palliative (P) | null | 2019-06-16 | Cisplatin + Doxorubicin | N | N | 310002637 | DABRAFENIB |
| 310005649 | 310002645 | 1.6 | null | Disease modification (D) | 2018-05-11 | 2018-05-25 | Doxorubicin + Olaratumab | N | N | 310002667 | CAPECITABINE + CARBOPLATIN |
| 310005650 | 310002645 | 0 | 75.7 | Palliative (P) | 2016-10-18 | 2016-11-15 | Bendamustine+Rituximab (1st Course) | 02 | N | 310002667 | DA |
| 310005651 | 310002645 | 1.71 | 85.5 | Palliative (P) | 2017-09-20 | 2017-09-20 | LENALIDOMIDE | 02 | N | 310002667 | IRINOTECAN + MDG |
| 310005652 | 310002645 | null | 87.6 | Curative (C) | 2018-09-14 | 2018-09-16 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | Y | N | 310002667 | SCOPE 1 TRIAL |
| 310005653 | 310002645 | 1.74 | null | Curative (C) | 2014-11-28 | 2014-11-29 | CVP | 02 | null | 310002667 | UKALL2011 |
| 310005654 | 310011473 | 1.73 | 0 | Palliative (P) | 2019-07-04 | 2019-07-04 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | 310003282 | DHAP - R |
| 310005655 | 310002646 | 1.58 | 0 | Palliative (P) | 2016-11-27 | 2017-01-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310003380 | DOCETAXEL |
| 310005656 | 310007091 | null | 91.5 | Palliative (P) | 2015-11-27 | 2015-11-27 | CYCLOPHOSPHAMIDE | N | null | 310003466 | G-CVP |
| 310005657 | 310007091 | 1.8 | 44.5 | Disease modification (D) | 2016-12-21 | 2016-12-21 | Capecitabine + Streptozocin | 2 | N | 310003466 | LOMUSTINE |
| 310005658 | 310002647 | 1.62 | null | Curative (C) | 2015-09-15 | 2015-09-29 | Carboplatin + Liposomal Doxorubicin | Y | N | 310003513 | IVA |
| 310005659 | 310002648 | 1.76 | null | Curative (C) | 2019-01-26 | 2019-01-28 | DABRAFENIB | 1 | N | 310003532 | BEP |
| 310005660 | 310002649 | null | 73.4 | Palliative (P) | 2013-12-08 | 2014-01-06 | FEC 60 or 75 | N | Y | 310003573 | IVE |
| 310005661 | 310002650 | null | 82 | Palliative (P) | 2016-07-21 | 2016-08-16 | FEC 100 | N | N | 310003715 | MITOMYCIN |
| 310005662 | 310002651 | 1.63 | 57.9 | Palliative (P) | 2018-08-16 | 2018-08-22 | CAPECITABINE + CARBOPLATIN | Y | N | 310003778 | PAZOPANIB |
| 310005663 | 310007092 | null | 112 | Curative (C) | 2019-02-17 | 2019-02-18 | CETUXIMAB + RT | 02 | N | 310004092 | DOCETAXEL |
| 310005664 | 310009304 | null | null | Palliative (P) | 2018-05-26 | 2018-05-27 | Lenalidomide 10mg (Cycle 1 to 25) | 02 | N | 310004229 | EDP |
| 310005665 | 310010466 | 1.64 | 69 | Palliative (P) | 2017-09-30 | 2017-10-11 | NHL 2003 Gp B COP | 02 | N | 310004395 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005666 | 310010466 | 1.69 | 62.1 | Palliative (P) | 2016-09-01 | 2016-09-05 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 310004395 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005667 | 310002652 | 1.72 | 70 | Palliative (P) | 2018-12-05 | 2018-12-09 | MITOMYCIN | null | N | 310005478 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005668 | 310002653 | 1.59 | 76.4 | Palliative (P) | 2015-05-31 | 2015-05-31 | IVE | N | N | 310007819 | CVP R |
| 310005669 | 310002654 | 1.6 | 0 | Palliative (P) | 2016-09-19 | 2016-10-02 | ICON8B TRIAL | Y | N | 310010359 | SUNITINIB |
| 310005670 | 310002655 | null | null | Palliative (P) | 2018-12-08 | 2018-12-27 | CVP R | N | N | 310010646 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 310005671 | 310002655 | 0 | 59.3 | Palliative (P) | 2018-10-04 | 2018-10-08 | Sunitinib | 02 | N | 310010646 | SUNITINIB |
| 310005672 | 310009305 | 1.82 | 84 | Palliative (P) | 2015-10-29 | 2015-11-04 | ALL UKALL60+ TRIAL | 2 | N | 310010912 | CVP |
| 310005673 | 310010467 | null | 109 | Adjuvant (A) | 2017-02-22 | 2017-03-07 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 2 | N | 310011301 | MITOMYCIN |
| 310005674 | 310011112 | 1.63 | null | Palliative (P) | 2018-08-28 | 2018-09-07 | TEMOZOLOMIDE | null | N | 310012020 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005675 | 310011112 | 1.66 | null | Curative (C) | 2018-07-04 | 2018-07-05 | Carbo + Topotecan (EPSSG RMS 2005) | 2 | N | 310012020 | CVP |
| 310005676 | 310011112 | 1.69 | 93 | null | null | 2017-04-12 | IVE | 2 | null | 310012020 | CISPLATIN + FLUOROURACIL + RT |
| 310005677 | 310002656 | 1.66 | 49.1 | Palliative (P) | 2015-02-14 | 2015-02-16 | Carboplatin + Liposomal Doxorubicin | N | N | 310013963 | METHOTREXATE INTRATHECAL |
| 310005678 | 310002657 | 1.61 | 0 | Curative (C) | 2018-12-12 | 2018-12-18 | Gemcitabine + Capecitabine | N | N | 310014095 | FEC + DOCETAXEL |
| 310005679 | 310007094 | 1.6 | null | null | 2015-09-24 | 2015-09-28 | Bevacizumab + Paclitaxel | N | null | 310015522 | DHAP |
| 310005680 | 310002658 | 0 | 61.4 | Curative (C) | 2017-01-25 | 2017-01-25 | Docetaxel + Gemcitabine (prior RT) | N | N | 310015827 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005681 | 310002659 | null | null | Curative (C) | null | 2015-11-27 | CETUXIMAB | 2 | N | 310016083 | CHLVPP |
| 310005682 | 310002659 | null | 97 | Palliative (P) | 2015-07-19 | 2014-09-03 | CARBOPLATIN + VINORELBINE | null | N | 310016083 | CISPLATIN + PEMETREXED |
| 310005683 | 310002660 | null | 78 | Curative (C) | 2014-03-07 | 2014-03-08 | CHLVPP | N | N | 310017476 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 310005684 | 310002660 | 1.7 | 63.5 | Curative (C) | 2018-08-22 | 2018-09-16 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 310017476 | CAPECITABINE + MITOMYCIN + RT |
| 310005685 | 310002661 | 1.61 | 49.2 | Palliative (P) | 2018-01-02 | 2018-01-08 | Folfirinox | 02 | Y | 310018380 | FEC |
| 310005686 | 310002662 | 1.63 | 86.9 | Curative (C) | 2018-10-23 | 2018-10-23 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 310020027 | CETUXIMAB + CISPLATIN + FU |
| 310005687 | 310002663 | 1.6 | 59 | Curative (C) | 2017-09-22 | 2017-10-04 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 2 | N | 310020425 | CARBOPLATIN + RT |
| 310005688 | 310007097 | null | 72.9 | Not known (9) | 2018-01-31 | 2018-02-01 | CARBOPLATIN + VINORELBINE | N | N | 310020507 | LANREOTIDE |
| 310005689 | 310002664 | 1.56 | null | Palliative (P) | 2018-07-03 | 2018-07-12 | ICON8B TRIAL | 02 | Y | 310020685 | FEC |
| 310005690 | 310002665 | 1.69 | 95.6 | Curative (C) | 2017-12-07 | 2017-12-13 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 310020717 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 310005691 | 310007098 | 1.51 | 56.4 | Disease modification (D) | 2018-01-17 | 2018-02-07 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 01 | N | 310020928 | METHOTREXATE INTRATHECAL |